glp 1 for menopausal women 20% of ages 50-64 have used GLP-1's making perimenopausal and women the TOP users of these drugs. Read more in this very informative article: https://www.rand.org/pubs/research_reports/RRA4153-1.html GLP-1 medications peri-menopause - Star

Concerns about suicidal ideation associated with GLP-1 receptor agonists have emerged from post-marketing reports, prompting regulatory investigation

The best starting place is honest self-assessment

Because it is a food-based protein, side effects are extremely rare

GLP-1 medications, such as semaglutide and tirzepatide, mimic the action of the hormone GLP-1 in the body, helping to regulate appetite, blood sugar levels, and promote feelings of fullness after meals

It was originally developed by Novo Nordisk and has been the subject of multiple Phase I and Phase II clinical trials, making it one of the better-characterised GHS peptides in terms of safety and pharmacokinetic data

Catalpol ameliorates LPS-induced inflammatory response by activating AMPK/mTOR signaling pathway in rat intestinal epithelial cells